Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11013793 Multivalent pneumococcal vaccines

Patent 11013793 was granted and assigned to Affinivax on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

May 25, 2021

Patent Application Number

16569579

Date Filed

September 12, 2019

Patent Citations

US Patent 10017548 Modified biotin-binding protein, fusion proteins thereof and applications

Patent Citations Received

US Patent 12090198 Combined vaccine against mycobacterium tuberculosis

0

US Patent 11576958 Protein antigens that provide protection against pneumococcal colonization and/or disease

US Patent 11976097 Modified biotin-binding protein, fusion proteins thereof and applications

0

US Patent 12083173 Protein antigens that provide protection against pneumococcal colonization and/or disease

0

US Patent 11560410 Modified biotin-binding protein, fusion proteins thereof and applications

US Patent 11701416 Multivalent pneumococcal vaccines

0

US Patent 11376323 Mixtures of polysaccharide protein pegylated compounds

Patent Primary Examiner

Patent abstract

Technologies for the prevention and/or treatment of pneumococcal infections.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11013793 Multivalent pneumococcal vaccines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool